4//SEC Filing
Calabrese Jeffrey 4
Accession 0001209191-22-041174
CIK 0001337553other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:44 PM ET
Size
10.9 KB
Accession
0001209191-22-041174
Insider Transaction Report
Form 4
Calabrese Jeffrey
Vice President of Finance
Transactions
- Award
Common Stock
2022-07-01+11,276→ 19,295 total - Award
Stock Option (right to buy)
2022-07-01+20,774→ 20,774 totalExercise: $8.36Exp: 2032-07-01→ Common Stock (20,774 underlying)
Footnotes (2)
- [F1]These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of July 1, 2022.
- [F2]This Option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of July 1, 2022.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001892279
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:44 PM ET
- Size
- 10.9 KB